Study of medication adherence with antiemetic drug therapy in breast cancer patients receiving chemotherapy.
Not Applicable
Completed
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000017753
- Lead Sponsor
- Keio University Graduate School of Health Management
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)more than PS2 2)receiving radiotherapy at present
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of taking medication adherence with antiemetic drug therapy
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie antiemetic drug efficacy in breast cancer chemotherapy?
How does adherence to antiemetic therapy impact treatment outcomes in breast cancer patients?
What biomarkers predict response to antiemetic drug therapy in breast cancer populations?
What adverse events are associated with antiemetic use in breast cancer chemotherapy regimens?
How does antiemetic adherence in breast cancer patients compare to other cancer types?